See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Natural Disasters
Social Media
Eid
Tariffs
Artificial Intelligence
Donald Trump
Education
Taxes
Stock Markets
US Politics
European Union
Senate
Published • loading... • Updated

Major Clinical Data: 52-Week Results for New Schizophrenia Drug Coming at SIRS 2025

Summary by stocktitan.net
New long-term Phase 3 efficacy and safety data for brilaroxazine in schizophrenia treatment spans 12 months of patient outcomes. Full analysis inside.

3 Articles

All
Left
Center
1
Right
BenzingaBenzinga
Center

Reviva to Present Brilaroxazine Topline Data for Long-Term OLE Portion of RECOVER Study in Schizophrenia at 2025 SIRS Congress - Reviva Pharmaceuticals (NASDAQ:RVPH)

CUPERTINO, Calif., March 30, 2025 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS), inflammatory and cardiometabolic diseases, announced today topline data from the long-term open label extension portion of the Phase 3 RECOVER study evaluating brilaroxazine in schizophrenia will be…

·New York, United States
Read Full Article
psychiatrictimes.compsychiatrictimes.com

Additional Positive Data on LB-102 for the Treatment of Acutely Exacerbated Schizophrenia

LB Pharmaceuticals presented additional positive data from NOVA1 exploring LB-102 in patients with acutely exacerbated schizophrenia, at the 2025 Annual Congress of the Schizophrenia International Research Society.

Read Full Article
stocktitan.netstocktitan.net

Major Clinical Data: 52-Week Results for New Schizophrenia Drug Coming at SIRS 2025

New long-term Phase 3 efficacy and safety data for brilaroxazine in schizophrenia treatment spans 12 months of patient outcomes. Full analysis inside.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Benzinga broke the news in New York, United States on Sunday, March 30, 2025.
Sources are mostly out of (0)

Similar News Topics

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

News
For You
SearchBlindspotLocal